Laurus Labs acquires stake in IIT Bombay incubated ImmunoACT
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Taluka level transplant centre will add convenience to patients from rural areas
It is used for the treatment of advanced colorectal and gastric cancer
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Nelarabine is in a class of medications called antimetabolites
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
Subscribe To Our Newsletter & Stay Updated